Education
About Us
Working with TipRanks
Follow Us
Medicover AB (SE:MCOV.B)
:MCOV.B
MCOV.B Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr170.40 - kr295.00
Previous CloseN/A
Volume18.87K
Average Volume (3M)94.53K
Market Cap
kr42.27B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)87.1
Beta0.53
Next Earnings
Nov 05, 2025EPS Estimate
1.55Last Dividend Ex-Date
Apr 30, 2025Dividend Yield0.52%
Share Statistics
EPS (TTM)1.42
Shares Outstanding74,355,095
10 Day Avg. Volume106,231
30 Day Avg. Volume94,530
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MCOV.B FAQ
What was Medicover AB’s price range in the past 12 months?
Medicover AB lowest stock price was kr170.40 and its highest was kr295.00 in the past 12 months.
What is Medicover AB’s market cap?
Medicover AB’s market cap is kr42.27B.
When is Medicover AB’s upcoming earnings report date?
Medicover AB’s upcoming earnings report date is Nov 05, 2025 which is in 97 days.
How were Medicover AB’s earnings last quarter?
Medicover AB released its earnings results on Jul 24, 2025. The company reported kr1.416 earnings per share for the quarter, beating the consensus estimate of kr1.327 by kr0.089.
Is Medicover AB overvalued?
According to Wall Street analysts Medicover AB’s price is currently Overvalued.
Does Medicover AB pay dividends?
Medicover AB pays a Annually dividend of kr1.448 which represents an annual dividend yield of 0.52%. See more information on Medicover AB dividends here
What is Medicover AB’s EPS estimate?
Medicover AB’s EPS estimate is 1.55.
How many shares outstanding does Medicover AB have?
Medicover AB has 74,355,095 shares outstanding.
What happened to Medicover AB’s price movement after its last earnings report?
Medicover AB reported an EPS of kr1.416 in its last earnings report, beating expectations of kr1.327. Following the earnings report the stock price went up 10.68%.
Which hedge fund is a major shareholder of Medicover AB?
Currently, no hedge funds are holding shares in SE:MCOV.B
Company Description
Medicover AB
Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
Technical Analysis
Ownership Overview
―
Insiders
2.49%
Mutual Funds
― Other Institutional Investors
94.08% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---